Nasdaq:US$18.41 (+0.16) | HKEX:HK$30.25 (+0.95) | AIM:£3.00 (+0.1)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 1 Apr 2014

AACR 2014: Anti-tumour activity of Epitinib in patient derived esophagus cancer models